Last reviewed · How we verify
NCT06754111
The Effect of Ideal Birth Environment on Birth Pain, Fear of Childbirth, Mode of Delivery and Duration of Delivery
NA trial testing ideal birth environment in Pregnant in 80 participants. Enrolling by invitation.
1 April 2025
Quick facts
| Lead sponsor | Mehmet Akif Ersoy University |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 80 |
| Start date | 1 October 2024 |
| Primary completion | 1 April 2025 |
| Estimated completion | 1 July 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- ideal birth environment
Conditions studied
- Pregnant — all drugs for Pregnant →
- Fear of Childbirth — all drugs for Fear of Childbirth →
- Ideal Birth Environment — all drugs for Ideal Birth Environment →
Sponsor
Mehmet Akif Ersoy University
Who can join
Adults 18 to 35, female only, with Pregnant or Fear of Childbirth. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study was to investigate whether the ideal birth environment is related to fear of childbirth, labor pain, duration of labor, and mode of delivery. on the impact of the study. The main questions it aims to answer are Does the ideal birth environment reduce fear of childbirth? Does the ideal birth environment reduce labor pain? does the ideal birth environment affect the duration of labor? In order to evaluate the effect of the ideal birth environment on fear, pain and duration of labor, the researchers will compare the standard delivery room and women who will give birth in a room customized for women, where they have their own sheets, pillows, items that make them feel special, where medical devices are reduced, in a room where they have photos with their partner, in a room where they listen to the music they want, where they have freedom of movement. both in the experimental and control groups: In the last trimester, the Wijma birth experience A version will be applied and in the postpartum period, the Wijma B Birth experience scale will be applied again and the fear of childbirth will be evaluated. Pain in labor will also be assessed using VAS (Visceral Visual Analgesic Scale) during the latent and active phase of labor.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06754111
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pregnant
Currently open trials in the same condition.
- NCT06239753 — The Impact of Dynamic Neuromuscular Stabilization on Pregnancy · NA · recruiting
- NCT04417283 — Project HOPE 1000: Health Outcomes Pregnancy Exposures · active not recruiting
Other Mehmet Akif Ersoy University trials
Trials by the same sponsor.
- NCT06941493 — Effect of Normal Birth Simulation and Podcast Training Given to Pregnant Women on Birth Fear, Belief and Self-Efficacy · not yet recruiting
- NCT06895330 — Effects of Virtual Reality and Helfer Skin Tap During Vaccination · NA · not yet recruiting
- NCT06898229 — Effect of Audiovisual Education on Breast Cancer · NA · active not recruiting
- NCT05474521 — Evaluation of Illinois Agility Performance With Smartphone Applications: A Validity and Reliability Study · NA · completed
- NCT05301374 — The Effect of Cartoon Watching During Central Venous Catheter Dressing Changes in Children With Cancer · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06754111 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mehmet Akif Ersoy University
- Last refreshed: 31 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06754111.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing